Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ACN
3. NVDA
4. GOOGL
5. MU
6. DFTX
7. USO
8. APGE
9. ABBV
10. NAVN

Go back to Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
(NASDAQ: AQST) Delayed: 4.72 --0 (-0%)
Previous Close $4.72    52 Week High $ 
Open $4.72    52 Week Low $ 
Day High $4.72    P/E N/A 
Day Low $4.72    EPS $ 
Volume 15,836